Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Tag: Lung Cancer Treatment
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…
Lung Cancer Cell “Memories” Suggest New Strategy for Improving Treatment
A new understanding of lung cancer cells “memories” suggest a new strategy for improving lung cancer treatment, according to Memorial Sloan Kettering Cancer Center (MSK) researchers. In this research, they have found…
Nanoparticle Vaccine Could Curb Lung Cancer Metastasis
The engineers at the University of California San Diego have come up with an experimental vaccine that could prevent the spread of metastatic cancers to the lung. The key ingredients of this…
J & J Lung Cancer Therapy Succeeds in Study with AstraZeneca’s Drug, Tagrisso
A head-to-head matchup between Johnson & Johnson combination and AstraZeneca’s drug, Tagrisso as a first-line treatment for non-small cell lung cancer has yielded J & J as the winner. In the MARIPOSA…
Tumor Treating Fields to Improve Survival Benefit in Lung Cancer
Tumor Treating Fields (TTFields) are electric fields that disrupt processes which are critical for the survival of cancer cells. This leads to immunogenic cell death and enhanced antitumor immune response. The use…
Israeli Researchers Identify Relapse-free Treatment for Lung Cancer
The research team of Weizmann Institute have identified biomarker that helps to prevent relapse of certain types of lung cancer. This new Israeli study could open ways to more efficient treatment for…
ctDNA Testing To Reduce Time For Lung Cancer Treatment
According to the American Society of Clinical Oncology, around 2.4lac adults in the United States will be diagnosed with lung cancer of which 81% are NSCLC. Early diagnosis and treatment is one…